FULLER H B CO Quarterly Cost of Revenue in USD from Q2 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Fuller H B Co quarterly/annual Cost of Revenue history and growth rate from Q2 2017 to Q4 2024.
  • Fuller H B Co Cost of Revenue for the quarter ending November 30, 2024 was $658M, a 4.67% increase year-over-year.
  • Fuller H B Co Cost of Revenue for the twelve months ending November 30, 2024 was $2.51B, a 0.19% increase year-over-year.
  • Fuller H B Co annual Cost of Revenue for 2024 was $2.51B, a 0.19% increase from 2023.
  • Fuller H B Co annual Cost of Revenue for 2023 was $2.5B, a 10.2% decline from 2022.
  • Fuller H B Co annual Cost of Revenue for 2022 was $2.79B, a 14.5% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $2.51B $658M +$29.4M +4.67% Sep 1, 2024 Nov 30, 2024 10-K 2025-01-23
Q3 2024 $2.48B $642M +$5.04M +0.79% Jun 2, 2024 Aug 31, 2024 10-Q 2024-09-26
Q2 2024 $2.47B $635M -$6.41M -1% Mar 3, 2024 Jun 1, 2024 10-Q 2024-06-27
Q1 2024 $2.48B $571M -$23.2M -3.9% Dec 3, 2023 Mar 2, 2024 10-Q 2024-03-28
Q4 2023 $2.5B $629M -$81.1M -11.4% Sep 3, 2023 Dec 2, 2023 10-K 2025-01-23
Q3 2023 $2.58B $637M -$54.9M -7.93% Jun 4, 2023 Sep 2, 2023 10-Q 2024-09-26
Q2 2023 $2.64B $641M -$98.3M -13.3% Mar 5, 2023 Jun 3, 2023 10-Q 2024-06-27
Q1 2023 $2.74B $594M -$49.2M -7.65% Dec 4, 2022 Mar 4, 2023 10-Q 2024-03-28
Q4 2022 $2.79B $710M +$54.1M +8.25% Aug 28, 2022 Dec 3, 2022 10-K 2025-01-23
Q3 2022 $2.73B $692M +$59.2M +9.35% May 29, 2022 Aug 27, 2022 10-Q 2023-09-28
Q2 2022 $2.67B $740M +$129M +21.2% Feb 27, 2022 May 28, 2022 10-Q 2023-06-29
Q1 2022 $2.54B $644M +$110M +20.6% Nov 28, 2021 Feb 26, 2022 10-Q 2023-03-30
Q4 2021 $2.43B $656M +$92M +16.3% Aug 29, 2021 Nov 27, 2021 10-K 2024-01-24
Q3 2021 $2.34B $633M +$129M +25.7% May 30, 2021 Aug 28, 2021 10-Q 2022-09-22
Q2 2021 $2.21B $610M +$121M +24.6% Feb 28, 2021 May 29, 2021 10-Q 2022-06-23
Q1 2021 $2.09B $534M +$57.2M +12% Nov 29, 2020 Feb 27, 2021 10-Q 2022-03-24
Q4 2020 $2.03B $564M +$26.1M +4.85% Aug 30, 2020 Nov 28, 2020 10-K 2023-01-24
Q3 2020 $2.01B $504M -$14.4M -2.79% May 31, 2020 Aug 29, 2020 10-Q 2021-09-23
Q2 2020 $2.02B $490M -$51.4M -9.5% Mar 1, 2020 May 30, 2020 10-Q 2021-06-29
Q1 2020 $2.07B $476M -$16.7M -3.39% Dec 1, 2019 Feb 29, 2020 10-Q 2021-03-25
Q4 2019 $2.09B $538M -$23.1M -4.12% Sep 1, 2019 Nov 30, 2019 10-K 2022-01-25
Q3 2019 $2.11B $518M -$37M -6.67% Jun 2, 2019 Aug 31, 2019 10-Q 2020-09-24
Q2 2019 $2.15B $541M -$28.1M -4.93% Mar 3, 2019 Jun 1, 2019 10-Q 2020-06-25
Q1 2019 $2.18B $493M -$34.6M -6.55% Dec 2, 2018 Mar 2, 2019 10-Q 2020-03-26
Q4 2018 $2.21B $561M Sep 2, 2018 Dec 1, 2018 10-K/A 2021-06-29
Q3 2018 $555M +$143M +34.6% Jun 3, 2018 Sep 1, 2018 10-Q 2019-09-27
Q2 2018 $569M +$154M +37% Mar 4, 2018 Jun 2, 2018 10-Q 2019-06-28
Q1 2018 $528M Dec 3, 2017 Mar 3, 2018 10-Q 2019-03-29
Q3 2017 $412M Jun 4, 2017 Sep 2, 2017 10-Q 2018-09-28
Q2 2017 $416M Mar 4, 2017 Jun 3, 2017 10-Q 2018-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.